Global Gene Therapy Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR102412791

Publication Date:

October 22, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Gene Therapy Medicine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Thepublisher report includes an overview of the development of the Gene Therapy Medicine industry chain, the market status of Cancer (Oral, Injection), Monogenic (Oral, Injection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapy Medicine.
Regionally, the report analyzes the Gene Therapy Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapy Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gene Therapy Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapy Medicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Injection).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapy Medicine market.
Regional Analysis: The report involves examining the Gene Therapy Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapy Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gene Therapy Medicine:
Company Analysis: Report covers individual Gene Therapy Medicine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapy Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Monogenic).
Technology Analysis: Report covers specific technologies relevant to Gene Therapy Medicine. It assesses the current state, advancements, and potential future developments in Gene Therapy Medicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapy Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gene Therapy Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oral
Injection
Market segment by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
Market segment by players, this report covers
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy Medicine, with revenue, gross margin and global market share of Gene Therapy Medicine from 2019 to 2024.
Chapter 3, the Gene Therapy Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Therapy Medicine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy Medicine.
Chapter 13, to describe Gene Therapy Medicine research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of Gene Therapy Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene Therapy Medicine by Type
1.3.1 Overview: Global Gene Therapy Medicine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Gene Therapy Medicine Consumption Value Market Share by Type in 2023
1.3.3 Oral
1.3.4 Injection
1.4 Global Gene Therapy Medicine Market by Application
1.4.1 Overview: Global Gene Therapy Medicine Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer
1.4.3 Monogenic
1.4.4 Infectious Disease
1.4.5 Cardiovascular Disease
1.4.6 Other
1.5 Global Gene Therapy Medicine Market Size & Forecast
1.6 Global Gene Therapy Medicine Market Size and Forecast by Region
1.6.1 Global Gene Therapy Medicine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Gene Therapy Medicine Market Size by Region, (2019-2030)
1.6.3 North America Gene Therapy Medicine Market Size and Prospect (2019-2030)
1.6.4 Europe Gene Therapy Medicine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Gene Therapy Medicine Market Size and Prospect (2019-2030)
1.6.6 South America Gene Therapy Medicine Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Gene Therapy Medicine Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Bluebird Bio
2.1.1 Bluebird Bio Details
2.1.2 Bluebird Bio Major Business
2.1.3 Bluebird Bio Gene Therapy Medicine Product and Solutions
2.1.4 Bluebird Bio Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bluebird Bio Recent Developments and Future Plans
2.2 Sangamo
2.2.1 Sangamo Details
2.2.2 Sangamo Major Business
2.2.3 Sangamo Gene Therapy Medicine Product and Solutions
2.2.4 Sangamo Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sangamo Recent Developments and Future Plans
2.3 Spark Therapeutics
2.3.1 Spark Therapeutics Details
2.3.2 Spark Therapeutics Major Business
2.3.3 Spark Therapeutics Gene Therapy Medicine Product and Solutions
2.3.4 Spark Therapeutics Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Spark Therapeutics Recent Developments and Future Plans
2.4 Dimension Therapeutics
2.4.1 Dimension Therapeutics Details
2.4.2 Dimension Therapeutics Major Business
2.4.3 Dimension Therapeutics Gene Therapy Medicine Product and Solutions
2.4.4 Dimension Therapeutics Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Dimension Therapeutics Recent Developments and Future Plans
2.5 Avalanche Bio
2.5.1 Avalanche Bio Details
2.5.2 Avalanche Bio Major Business
2.5.3 Avalanche Bio Gene Therapy Medicine Product and Solutions
2.5.4 Avalanche Bio Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Avalanche Bio Recent Developments and Future Plans
2.6 Celladon
2.6.1 Celladon Details
2.6.2 Celladon Major Business
2.6.3 Celladon Gene Therapy Medicine Product and Solutions
2.6.4 Celladon Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Celladon Recent Developments and Future Plans
2.7 Vical Inc.
2.7.1 Vical Inc. Details
2.7.2 Vical Inc. Major Business
2.7.3 Vical Inc. Gene Therapy Medicine Product and Solutions
2.7.4 Vical Inc. Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Vical Inc. Recent Developments and Future Plans
2.8 Advantagene
2.8.1 Advantagene Details
2.8.2 Advantagene Major Business
2.8.3 Advantagene Gene Therapy Medicine Product and Solutions
2.8.4 Advantagene Gene Therapy Medicine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Advantagene Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Therapy Medicine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Gene Therapy Medicine by Company Revenue
3.2.2 Top 3 Gene Therapy Medicine Players Market Share in 2023
3.2.3 Top 6 Gene Therapy Medicine Players Market Share in 2023
3.3 Gene Therapy Medicine Market: Overall Company Footprint Analysis
3.3.1 Gene Therapy Medicine Market: Region Footprint
3.3.2 Gene Therapy Medicine Market: Company Product Type Footprint
3.3.3 Gene Therapy Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Gene Therapy Medicine Consumption Value and Market Share by Type (2019-2024)
4.2 Global Gene Therapy Medicine Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Gene Therapy Medicine Consumption Value Market Share by Application (2019-2024)
5.2 Global Gene Therapy Medicine Market Forecast by Application (2025-2030)
6 North America
6.1 North America Gene Therapy Medicine Consumption Value by Type (2019-2030)
6.2 North America Gene Therapy Medicine Consumption Value by Application (2019-2030)
6.3 North America Gene Therapy Medicine Market Size by Country
6.3.1 North America Gene Therapy Medicine Consumption Value by Country (2019-2030)
6.3.2 United States Gene Therapy Medicine Market Size and Forecast (2019-2030)
6.3.3 Canada Gene Therapy Medicine Market Size and Forecast (2019-2030)
6.3.4 Mexico Gene Therapy Medicine Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Gene Therapy Medicine Consumption Value by Type (2019-2030)
7.2 Europe Gene Therapy Medicine Consumption Value by Application (2019-2030)
7.3 Europe Gene Therapy Medicine Market Size by Country
7.3.1 Europe Gene Therapy Medicine Consumption Value by Country (2019-2030)
7.3.2 Germany Gene Therapy Medicine Market Size and Forecast (2019-2030)
7.3.3 France Gene Therapy Medicine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Gene Therapy Medicine Market Size and Forecast (2019-2030)
7.3.5 Russia Gene Therapy Medicine Market Size and Forecast (2019-2030)
7.3.6 Italy Gene Therapy Medicine Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Gene Therapy Medicine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Gene Therapy Medicine Market Size by Region
8.3.1 Asia-Pacific Gene Therapy Medicine Consumption Value by Region (2019-2030)
8.3.2 China Gene Therapy Medicine Market Size and Forecast (2019-2030)
8.3.3 Japan Gene Therapy Medicine Market Size and Forecast (2019-2030)
8.3.4 South Korea Gene Therapy Medicine Market Size and Forecast (2019-2030)
8.3.5 India Gene Therapy Medicine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Gene Therapy Medicine Market Size and Forecast (2019-2030)
8.3.7 Australia Gene Therapy Medicine Market Size and Forecast (2019-2030)
9 South America
9.1 South America Gene Therapy Medicine Consumption Value by Type (2019-2030)
9.2 South America Gene Therapy Medicine Consumption Value by Application (2019-2030)
9.3 South America Gene Therapy Medicine Market Size by Country
9.3.1 South America Gene Therapy Medicine Consumption Value by Country (2019-2030)
9.3.2 Brazil Gene Therapy Medicine Market Size and Forecast (2019-2030)
9.3.3 Argentina Gene Therapy Medicine Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Gene Therapy Medicine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Gene Therapy Medicine Market Size by Country
10.3.1 Middle East & Africa Gene Therapy Medicine Consumption Value by Country (2019-2030)
10.3.2 Turkey Gene Therapy Medicine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Gene Therapy Medicine Market Size and Forecast (2019-2030)
10.3.4 UAE Gene Therapy Medicine Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Gene Therapy Medicine Market Drivers
11.2 Gene Therapy Medicine Market Restraints
11.3 Gene Therapy Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Gene Therapy Medicine Industry Chain
12.2 Gene Therapy Medicine Upstream Analysis
12.3 Gene Therapy Medicine Midstream Analysis
12.4 Gene Therapy Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂